GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.
Specialty pharmaceutical firm for rare diseases and unmet medical needs.
GENIL | IS
Overview
Corporate Details
- ISIN(s):
- TREGENL00016 (+1 more)
- LEI:
- 789000A4NW6W4D8Z4H25
- Country:
- Türkiye
- Address:
- MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA
- Website:
- https://www.genilac.com.tr
- Sector:
- Manufacturing
Description
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. is a specialty pharmaceutical company established in 1998 that provides solutions for rare diseases and unmet medical needs. The company operates a GMP-certified manufacturing facility and an R&D center to develop, produce, and supply a wide range of products for international markets. Its business model combines strategic partnerships with global firms and in-house innovation to address complex health challenges, leveraging over 25 years of experience in its specialized therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-17 13:56 |
Sustainability Report for 2023
|
Turkish | HTML • 18.4 KB | ||
| 2024-12-04 10:55 |
Company General Info Form
|
English | HTML • 12.4 KB | ||
| 2024-12-04 10:55 |
Additional Investment to Stimusil Inc.
|
English | HTML • 94.4 KB | ||
| 2024-11-20 15:03 |
Solar Power Plant Project Update
|
Turkish | HTML • 22.0 KB | ||
| 2024-11-20 10:16 |
2024 Yılı 3. Çeyrek Analist Sunumu
|
Turkish | PDF • 4.4 MB | ||
| 2024-11-20 10:16 |
2024 Yılı 3. Çeyrek Analist Sunumu
|
English | HTML • 17.1 KB | ||
| 2024-11-11 16:11 |
01.01.2024 - 30.09.2024 Interim Period Activity Report
|
Turkish | PDF • 668.3 KB | ||
| 2024-11-11 16:11 |
01.01.2024 - 30.09.2024 Interim Period Activity Report
|
Turkish | PDF • 778.7 KB | ||
| 2024-11-11 16:11 |
01.01.2024 - 30.09.2024 Interim Period Activity Report
|
English | HTML • 11.1 KB | ||
| 2024-11-11 16:10 |
Financial Report
|
Turkish | PDF • 715.1 KB | ||
| 2024-11-11 16:10 |
Financial Report
|
English | HTML • 2.6 MB | ||
| 2024-11-11 16:10 |
01.01.2024 - 30.09.2024 Sorumluluk Beyanı
|
Turkish | HTML • 23.2 KB | ||
| 2024-11-08 14:14 |
Tender Result Notified by the Organization which Authorized by Our Company
|
Turkish | HTML • 19.9 KB | ||
| 2024-10-18 16:24 |
Company General Info Form
|
Turkish | HTML • 12.4 KB | ||
| 2024-10-18 16:24 |
Increase in GEN's shares on Elixir A.Ş.
|
English | HTML • 91.0 KB |
Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
